Efavirenz significantly affects pharmacokinetic exposure of artemether-lumefantrine in HIV-infected Ugandan adults

被引：0

作者：

Byakika-Kibwika, P. ^{[1
]}

机构：

[1] Makerere Univ, Infect Dis Inst, Kampala, Uganda

来源：

TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2012年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：40 / 41

页数：2

共 50 条

[41] Simultaneous Population Pharmacokinetic Model for Lopinavir and Ritonavir in HIV-Infected Adults [J].

José Moltó ;

Manuel José Barbanoj ;

Cristina Miranda ;

Asunción Blanco ;

José Ramón Santos ;

Eugenia Negredo ;

Joan Costa ;

Pere Domingo ;

Bonaventura Clotet ;

Marta Valle .

Clinical Pharmacokinetics, 2008, 47 :681-692

[42] Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults [J].

Molto, Jose ;

Barbanoj, Manuel Jose ;

Miranda, Cristina ;

Blanco, Asuncion ;

Santos, Jose Ramon ;

Negredo, Eugenia ;

Costa, Joan ;

Domingo, Pere ;

Clotet, Bonaventura ;

Valle, Marta .

CLINICAL PHARMACOKINETICS, 2008, 47 (10) :681-692

[43] Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections [J].

Tokman, Sofya ;

Barnett, Christopher F. ;

Jarlsberg, Leah G. ;

Taub, Pam R. ;

Den Boon, Saskia ;

Davis, J. Lucian ;

Cattamanchi, Adithya ;

Worodria, William ;

Maisel, Alan ;

Huang, Laurence .

RESPIROLOGY, 2014, 19 (03) :382-388

[44] Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in HIV-positive Tanzanian adults receiving first-line antiretrovirals [J].

Vestergaard, L. S. ;

Nyagonde, N. ;

Cundill, B. ;

Duong, T. ;

Sebe, W. Sebe ;

Francis, F. ;

Persson, O. ;

Helleberg, M. ;

Asbjoern, J. ;

Amos, B. ;

Wiesner, L. ;

Barnes, K. ;

Alifrangis, M. ;

Lemnge, M. M. ;

Bygbjerg, I. C. .

TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 :14-15

[45] Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan Adults [J].

Ellis, Jayne ;

Cresswell, Fiona V. ;

Joshua, Rhein ;

Kenneth, Ssebambulidde ;

Boulware, David R. .

OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (08)

[46] Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial) [J].

Molina, JM ;

Peytavin, G ;

Perusat, S ;

Lascoux-Combes, C ;

Sereni, D ;

Rozenbaum, W ;

Chene, G .

HIV MEDICINE, 2004, 5 (02) :99-104

[47] Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women [J].

Cohan, Deborah ;

Natureeba, Paul ;

Koss, Catherine A. ;

Plenty, Albert ;

Luwedde, Flavia ;

Mwesigwa, Julia ;

Ades, Veronica ;

Charlebois, Edwin D. ;

Gandhi, Monica ;

Clark, Tamara D. ;

Nzarubara, Bridget ;

Achan, Jane ;

Ruel, Theodore ;

Kamya, Moses R. ;

Havlir, Diane V. .

AIDS, 2015, 29 (02) :183-191

[48] Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic-Pharmacogenetic Model of HIV-infected Patients in Thailand [J].

Chaivichacharn, Piyawat ;

Avihingsanon, Anchalee ;

Manosuthi, Weerawat ;

Ubolyam, Sasiwimol ;

Tongkobpetch, Siraprapa ;

Shotelersuk, Vorasuk ;

Punyawudho, Baralee .

CLINICAL THERAPEUTICS, 2020, 42 (07) :1234-1245

[49] Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children [J].

Stevens, RC ;

Rodman, JH ;

Yong, FH ;

Carey, V ;

Knupp, CA ;

Frenkel, LM .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (05) :415-421

[50] Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children [J].

Bienczak, Andrzej ;

Denti, Paolo ;

Cook, Adrian ;

Wiesner, Lubbe ;

Mulenga, Veronica ;

Kityo, Cissy ;

Kekitiinwa, Addy ;

Gibb, Diana M. ;

Burger, David ;

Walker, Sarah ;

McIlleron, Helen .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (02) :161-168

← 1 2 3 4 5 →